Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy and Ozempic contain the same active ingredient—semaglutide—yet they are packaged and prescribed for different purposes. Ozempic targets blood sugar control in adults with type 2 diabetes, while Wegovy was specifically developed for chronic weight management in people without diabetes. Both medications activate GLP-1 receptors in the brain to reduce hunger and increase fullness, producing measurable weight loss in clinical trials.
What Is Semaglutide and How Does It Work for Weight Loss
Semaglutide is a glucagon-like peptide-1 receptor agonist that mimics a natural hormone your gut produces after eating. When you take semaglutide, it signals your brain's appetite control centers to decrease hunger while slowing how fast your stomach empties food. This dual mechanism helps you feel satisfied with smaller portions and eat less throughout the day.
Clinical studies show that adults using semaglutide lose 15-22% of their body weight over 68 weeks compared to about 2% with diet and exercise alone. The medication works best when combined with lifestyle changes like eating nutrient-dense foods and regular physical activity. PlexusDx offers compounded semaglutide injection starting at $149 per month through licensed 503A pharmacies available in all 50 states.
Wegovy vs Ozempic: Key Differences in Approved Uses
Wegovy received FDA approval in 2021 specifically for chronic weight management in adults with obesity or overweight conditions plus at least one weight-related health issue. Ozempic was approved in 2017 for type 2 diabetes treatment and helps lower blood sugar levels in addition to producing weight loss as a side effect. Both contain identical semaglutide molecules, but they carry different labels, dosing schedules, and insurance coverage pathways.
Your doctor determines which medication is appropriate based on your diagnosis and medical history. Someone with type 2 diabetes might be prescribed Ozempic for glucose control with weight loss as a benefit, while a person focused on weight management without diabetes would use Wegovy. PlexusDx provides prescription compounded semaglutide that your doctor can prescribe for appropriate medical conditions, offering flexibility across all 50 states without requiring insurance.
Dosing Schedules and How They Build Up Over Time
Both Wegovy and Ozempic start at low doses that increase gradually every four weeks to minimize side effects and allow your body to adapt. Wegovy begins at 0.25 mg weekly, stepping up to 0.5 mg, then 1.0 mg, 1.7 mg, and finally 2.4 mg over five months. Ozempic follows a similar pattern but may continue adjusting based on your blood sugar response rather than reaching a fixed maintenance dose.
The gradual dose escalation reduces nausea, vomiting, and digestive discomfort that some people experience when starting GLP-1 therapy. Most people see meaningful weight loss within the first month, with continued progress as doses increase. With PlexusDx compounded semaglutide injection, your dose adjusts to meet your individual response—and your price remains flat at $149 per month, so you never pay more as your prescription strengthens.
Comparing Side Effects, Safety, and Long-Term Outcomes
Both medications share a similar side effect profile: nausea, vomiting, diarrhea, and constipation are most common during the dose-buildup phase and often decrease over time. Rare but serious concerns include pancreatitis, thyroid tumors (in animal studies), and gallbladder issues, making it important to disclose your full medical history before starting. Most people tolerate semaglutide well, and the digestive side effects typically resolve within weeks as your body adjusts.
Long-term data shows that people who stop taking semaglutide gradually regain weight, making ongoing treatment a commitment rather than a one-time fix. Clinical trials demonstrate that continuing treatment maintains weight loss and prevents weight rebound better than placebo. PlexusDx supports long-term success through ongoing medical supervision and the option to add the Precision Peptide Genetic Test ($99 after your first month) to identify genetic pathways affecting your response to treatment.
Why Choose Compounded Semaglutide Through PlexusDx
PlexusDx compounded semaglutide injection from licensed 503A pharmacies offers the same active ingredient as brand-name Wegovy and Ozempic at a lower cost with greater accessibility. You avoid insurance approval delays and coverage denials, pay one flat monthly price of $149 regardless of your dose level, and qualify for HSA and FSA contributions. Compounded medications require the same quality standards and pharmacist oversight as brand-name drugs, ensuring safety and efficacy.
PlexusDx serves all 50 states without membership fees and provides optional genetic testing through the Precision Peptide Genetic Test to personalize your treatment approach. The test analyzes 14 peptide pathways and 150+ genetic insights, including variants in GLP1R and GIPR that influence how effectively your body responds to semaglutide. By understanding your genetic predispositions, you and your doctor can optimize your dosing and choose the best compound form—injection or oral—for your lifestyle and goals.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I use Ozempic instead of Wegovy if I don't have diabetes?
Ozempic is FDA-approved only for type 2 diabetes, so prescribing it off-label for weight loss alone carries different insurance and liability considerations. Your doctor may choose to do so, but Wegovy is the officially approved option for weight management without diabetes. PlexusDx compounded semaglutide injection works identically to both and starts at $149 per month across all 50 states.
How much weight do most people lose on semaglutide?
Clinical trials show average weight loss of 15-22% of body weight over 68 weeks with semaglutide, compared to about 2% with diet and exercise alone. Individual results vary based on starting weight, lifestyle adherence, genetics, and how your body's GLP-1 receptors respond to the medication. PlexusDx's optional Precision Peptide Genetic Test identifies genetic factors affecting your response, helping predict your likely success.
What does PlexusDx semaglutide cost compared to Wegovy?
PlexusDx compounded semaglutide injection starts at $149 per month with a flat-rate pricing model—your dose can increase without raising your monthly cost. Brand-name Wegovy typically costs $900-$1,300 per month without insurance, and many insurance plans deny or delay coverage. PlexusDx works in all 50 states, requires no insurance, and qualifies for HSA and FSA accounts.
Are there serious side effects I should know about?
The most common side effects are nausea, vomiting, and diarrhea during dose escalation, which usually improve as your body adjusts. Rare serious risks include pancreatitis, gallbladder problems, and thyroid concerns, so full medical history disclosure is essential. PlexusDx ensures you receive ongoing physician oversight and can pause or adjust treatment if side effects become problematic.
What does the Precision Peptide Genetic Test tell me?
PlexusDx's Precision Peptide Genetic Test ($99 after your first month) analyzes 49 peptides across 14 pathways, including GLP1R and GIPR variants that influence semaglutide effectiveness. The test identifies whether your genetics predict strong, moderate, or weaker response to GLP-1 therapy, helping your doctor optimize dosing and compound selection. This personalized insight increases your chances of success and allows earlier adjustments if needed.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Routine: What Time of Day Should I Take My Ozempic?
How Quickly Do Wegovy Side Effects Start?